Table 3.
(p < 0.05) correlations between model parameters and DQLFT patient blood measurements.
| Model parameters |
Day 7 ALT Correlation Coefficient n = 9 |
P | Month 6 Bilirubin Correlation Coefficient n = 7 |
p |
|---|---|---|---|---|
| TNF | 0.7326 | 0.02 | −0.7598 | 0.048 |
| Jak | 0.7339 | 0.02 | −0.7601 | 0.047 |
| Stat3 | 0.7439 | 0.02 | −0.7615 | 0.047 |
| SOC | 0.7288 | 0.03 | −0.7601 | 0.047 |
| ECM | −0.7195 | 0.03 | 0.7608 | 0.047 |
| IE | 0.7430 | 0.02 | −0.7592 | 0.048 |
| GF | 0.7356 | 0.02 | −0.7604 | 0.047 |
| Q | −0.7200 | 0.03 | 0.7594 | 0.048 |
| P | 0.6903 | 0.04 | −0.7698 | 0.043 |
| R | 0.7324 | 0.02 | ||
| Q+P+R | −0.7040 | 0.03 | 0.7612 | 0.047 |
TNF, tumor necrosis factor; JAK, Janus kinase; STAT3, signal transducer and activator of transcription 3; SOC, suppressor of cytokine signaling; ECM, extracellular matrix; IE, intermediate-early genes; GF, growth factor; Q, quiescent hepatocytes; P, primed hepatocytes; R, replicating hepatocytes.